Ancestry-related variation, such as the higher frequency of RNF43 mutations in untreated H/L EOCRC patients, could be influenced by differences in genetic background, environmental exposures, or host–tumor interactions, including inflammation or microbiome composition, which have been shown to modulate WNT signaling. Here, RNF43 is linked to neoplasm.